Categories: News

Precision BioSciences to Present at the Annual J.P. Morgan Healthcare Conference

DURHAM, N.C., Jan. 04, 2021 (GLOBE NEWSWIRE) — Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company dedicated to improving life with its novel and proprietary ARCUS® genome editing platform, today announced that Matt Kane, Co-founder and Chief Executive Officer and Derek Jantz, Ph.D., Co-Founder and Chief Scientific Officer, will present at the 39th Annual J.P. Morgan Healthcare Conference taking place virtually from January 11-14, 2021.

Details for the company presentation are as follows:

39th Annual J.P. Morgan Healthcare Conference
Date: Wednesday, January 13, 2021
Time: 2:00 – 2:40 p.m. ET

A live webcast of the presentation will be accessible on the Company’s website, www.precisionbiosciences.com, in the Investors & Media section under Events and Presentations. An archived replay of the webcasts will be available for approximately 30 days following the presentations.

About Precision BioSciences, Inc.
Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform. ARCUS is a highly specific and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company’s pipeline consists of multiple “off-the-shelf” CAR T immunotherapy clinical candidates and several in vivo gene correction therapy candidates to cure genetic and infectious diseases where no adequate treatments exist. For more information about Precision BioSciences, please visit www.precisionbiosciences.com.

Investor Contact:
Alex Kelly
Interim Chief Financial Officer
Alex.Kelly@precisionbiosciences.com

Media Contact:
Maurissa Messier
Senior Director, Corporate Communications
Maurissa.Messier@precisionbiosciences.com

Staff

Recent Posts

TruBridge Ranked as a Top Provider by Black Book in Its 2024 Report of Top Client-Rated Financial and RCM Solutions

TruBridge Awarded for Performance in Client Experience and Customer Satisfaction: End-to-end RCM Software Outsourcing, Hospitals…

2 mins ago

Tebra Releases New Product Enhancements to Give Independent Healthcare Providers More Time with Patients

New survey finds 85% of responding independent healthcare providers say more time with patients would…

3 mins ago

BioHarvest Sciences Announces Closing of USD $4,329,982 in First Tranche of Private Placement and Conversion of Debt Notes

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 28, 2024) - BioHarvest Sciences Inc. (CSE:…

7 mins ago

samrecover(R) Sponsors NFL Player Derrick Gore’s Youth Football Camp

Inventors of the sustained acoustic medicine ultrasound treatment, popular with football players and other athletes…

7 mins ago

Nashville-Based ObjectiveHealth, QualDerm Partners Expand Partnership to Increase Care Options for Patients

NASHVILLE, Tenn.--(BUSINESS WIRE)--#aesthetics--ObjectiveHealth, a Nashville-based integrated research and technology platform company, announced today that it…

3 hours ago

Data from Anumana’s New Study Show AI Algorithm Has the Potential to Detect Pulmonary Hypertension Early Using ECG Data

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leading AI-driven health technology company and portfolio company of nference, announced…

3 hours ago